See more : Shanghai Oriental Pearl Group Co., Ltd. (600637.SS) Income Statement Analysis – Financial Results
Complete financial analysis of Kane Biotech Inc. (KNE.V) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Kane Biotech Inc., a leading company in the Biotechnology industry within the Healthcare sector.
- PT Perintis Triniti Properti Tbk (TRIN.JK) Income Statement Analysis – Financial Results
- PROGRIT Inc. (9560.T) Income Statement Analysis – Financial Results
- Asia Polymer Corporation (1308.TW) Income Statement Analysis – Financial Results
- Heritage Foods Limited (HERITGFOOD.BO) Income Statement Analysis – Financial Results
- Heartland Group Holdings Limited (HGH.NZ) Income Statement Analysis – Financial Results
Kane Biotech Inc. (KNE.V)
About Kane Biotech Inc.
Kane Biotech Inc., a biotechnology company, engages in the research, development, and commercialization of technologies and products that prevent and remove microbial biofilms in Canada and internationally. The company develops pet oral care products under the StrixNB and bluestem brands; animal and human wound care solutions under the DispersinB name; shampoos for dogs, cats, and horses under the Alosera name; and medical device coatings under the Aledex name. It also offers scalp care products under the DermaKB brand name, wound care products under the Coactiv+ brand name, as well as other products under the goldstem, silkstem, and DermaKB Biofilm brand names. Kane Biotech Inc. was incorporated in 2001 and is based in Winnipeg, Canada.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 148.98K | 2.67M | 1.61M | 1.34M | 1.69M | 506.27K | 1.04M | 244.76K | 104.62K | 41.90K | 159.95K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 17.16K | 24.10K | 0.00 | 13.41K | 76.64K |
| Cost of Revenue | 39.51K | 1.26M | 1.04M | 814.72K | 1.08M | 390.80K | 122.40K | 124.23K | 45.03K | 19.57K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 109.47K | 1.41M | 568.44K | 526.86K | 609.91K | 115.47K | 912.90K | 120.53K | 59.59K | 22.33K | 159.95K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 17.16K | 24.10K | 0.00 | 13.41K | 76.64K |
| Gross Profit Ratio | 73.48% | 52.96% | 35.36% | 39.27% | 36.01% | 22.81% | 88.18% | 49.25% | 56.96% | 53.29% | 100.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 100.00% | 100.00% | 0.00% | 100.00% | 100.00% |
| Research & Development | 1.29M | 1.05M | 1.38M | 1.33M | 1.54M | 922.53K | 850.58K | 573.42K | 403.86K | 757.40K | 48.95K | 176.80K | 146.51K | 423.75K | 325.81K | 520.30K | 423.70K | 415.82K | 430.95K | 275.48K | 167.58K |
| General & Administrative | 2.41M | 3.72M | 4.07M | 3.43M | 2.66M | 2.37M | 2.76M | 2.12M | 1.39M | 787.92K | 1.23M | 1.20M | 1.02M | 476.69K | 505.05K | 487.68K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 2.41M | 3.72M | 4.07M | 3.43M | 2.66M | 2.37M | 2.76M | 2.12M | 1.39M | 787.92K | 1.23M | 1.20M | 1.02M | 476.69K | 505.05K | 487.68K | 577.56K | 440.89K | 564.80K | 324.53K | 296.17K |
| Other Expenses | -232.86K | 254.90K | 323.80K | 460.05K | 108.62K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -5.30K | 6.67K | 6.65K | 26.65K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 3.47M | 4.78M | 5.45M | 4.75M | 4.20M | 3.29M | 3.61M | 2.69M | 1.79M | 1.55M | 1.61M | 1.46M | 1.24M | 929.41K | 870.36K | 1.05M | 1.05M | 892.58K | 1.04M | 615.98K | 482.18K |
| Cost & Expenses | 3.51M | 6.03M | 6.49M | 5.57M | 5.28M | 3.69M | 3.73M | 2.81M | 1.84M | 1.56M | 1.61M | 1.46M | 1.24M | 929.41K | 870.36K | 1.05M | 1.05M | 892.58K | 1.04M | 615.98K | 482.18K |
| Interest Income | 5.67K | 100.35K | 121.93K | 38.30K | 454.00 | 9.62K | 15.89K | 9.39K | 5.25K | 6.87K | 10.94K | 12.80K | 20.19K | 0.00 | 0.00 | 0.00 | 17.16K | 24.10K | 22.12K | 13.41K | 19.75K |
| Interest Expense | 1.22M | 822.21K | 416.06K | 121.56K | 141.68K | 89.78K | 90.76K | 120.52K | 106.37K | 101.46K | 4.09K | 4.99K | 786.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 116.05K | 257.68K | 187.97K | 78.11K | 54.42K | 71.78K | 69.39K | 48.98K | 42.56K | 39.24K | 35.44K | 35.48K | 28.40K | 28.97K | 39.49K | 42.29K | 105.86K | 35.88K | 33.14K | 15.97K | 18.43K |
| EBITDA | -3.23M | -2.95M | -4.25M | -3.65M | -764.08K | -3.10M | -3.24M | -2.38M | -1.56M | -1.47M | -1.36M | -1.42M | -1.19M | -943.84K | -837.76K | -1.03M | -929.26K | -832.61K | -969.55K | -586.60K | -406.86K |
| EBITDA Ratio | -2,171.04% | -102.88% | -264.33% | -271.91% | -202.34% | -611.81% | -252.07% | -1,027.30% | -1,608.27% | -3,518.37% | -841.25% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -5,416.52% | -3,455.10% | 0.00% | -4,373.02% | -505.10% |
| Operating Income | -3.36M | -3.36M | -4.88M | -4.22M | -3.59M | -3.18M | -2.69M | -2.43M | -1.61M | -1.52M | -1.45M | -1.46M | -1.24M | -979.92K | -883.89K | -997.05K | -1.04M | -868.49K | -1.04M | -602.56K | -405.54K |
| Operating Income Ratio | -2,253.58% | -126.06% | -303.75% | -314.88% | -212.00% | -627.89% | -260.31% | -994.67% | -1,541.11% | -3,634.89% | -906.95% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -6,033.56% | -3,603.98% | 0.00% | -4,492.04% | -529.15% |
| Total Other Income/Expenses | -1.20M | -564.03K | 33.65K | 378.40K | 2.63M | -82.17K | -91.22K | -114.23K | -97.62K | -91.93K | 3.25K | 4.41K | 14.10K | 6.67K | -6.89K | -26.57K | -54.84K | -87.27K | -6.96K | 0.00 | 0.00 |
| Income Before Tax | -4.56M | -3.82M | -4.85M | -3.85M | -960.18K | -3.26M | -2.79M | -2.55M | -1.71M | -1.61M | -1.45M | -1.46M | -1.24M | -1.02M | -890.78K | -1.02M | -1.09M | -955.76K | -1.03M | 0.00 | 0.00 |
| Income Before Tax Ratio | -3,062.39% | -143.31% | -301.65% | -286.68% | -56.70% | -644.12% | -269.12% | -1,041.34% | -1,634.42% | -3,854.29% | -904.91% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -6,353.20% | -3,966.13% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | 0.00 | 1.14M | 494.51K | 452.32K | 250.30K | 89.78K | 90.76K | 120.52K | 106.37K | 101.46K | 62.80K | 146.16K | 21.48K | 50.51K | 13.54K | 53.22K | 0.00 | 0.00 | -15.87K | 0.00 | 0.00 |
| Net Income | -5.03M | -3.89M | -4.60M | -3.72M | -960.18K | -3.26M | -2.79M | -2.55M | -1.71M | -1.61M | -1.45M | -1.46M | -1.22M | -973.25K | -877.25K | -1.08M | -1.09M | -955.76K | -1.01M | -602.56K | -405.54K |
| Net Income Ratio | -3,379.05% | -145.78% | -286.39% | -277.04% | -56.70% | -644.12% | -269.12% | -1,041.34% | -1,634.42% | -3,854.29% | -904.91% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -6,353.20% | -3,966.13% | 0.00% | -4,492.04% | -529.15% |
| EPS | -0.04 | -0.03 | -0.04 | -0.03 | -0.01 | -0.04 | -0.05 | -0.07 | -0.08 | -0.08 | -0.08 | -0.10 | -0.10 | -0.11 | -0.13 | -0.19 | -0.26 | -0.26 | -0.31 | -0.22 | -0.21 |
| EPS Diluted | -0.04 | -0.03 | -0.04 | -0.03 | -0.01 | -0.04 | -0.05 | -0.07 | -0.08 | -0.08 | -0.08 | -0.10 | -0.10 | -0.11 | -0.13 | -0.19 | -0.26 | -0.26 | -0.31 | -0.22 | -0.21 |
| Weighted Avg Shares Out | 140.26M | 120.70M | 112.60M | 107.55M | 82.30M | 80.11M | 61.28M | 37.68M | 21.92M | 19.03M | 18.01M | 14.04M | 12.55M | 8.52M | 6.55M | 5.54M | 4.15M | 3.64M | 3.30M | 2.75M | 1.92M |
| Weighted Avg Shares Out (Dil) | 127.12M | 120.70M | 112.60M | 107.55M | 82.30M | 80.11M | 61.28M | 37.68M | 21.92M | 19.03M | 18.01M | 14.04M | 12.55M | 8.52M | 6.55M | 5.54M | 4.15M | 3.64M | 3.30M | 2.75M | 1.92M |
Source: https://incomestatements.info
Category: Stock Reports